Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

Kunwar S, Prados MD, Chang SM, Berger MS, Lang FF, Piepmeier JM, Sampson JH, Ram Z, Gutin PH, Gibbons RD, Aldape KD, Croteau DJ, Sherman JW, Puri RK; Cintredekin Besudotox Intraparenchymal Study Group.

J Clin Oncol. 2007 Mar 1;25(7):837-44.

PMID:
17327604
2.

Cintredekin besudotox in treatment of malignant glioma.

Mut M, Sherman JH, Shaffrey ME, Schiff D.

Expert Opin Biol Ther. 2008 Jun;8(6):805-12. doi: 10.1517/14712598.8.6.805 . Review.

PMID:
18476792
3.

Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside.

Husain SR, Puri RK.

J Neurooncol. 2003 Oct;65(1):37-48. Review.

PMID:
14649884
4.

The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy.

Shimamura T, Husain SR, Puri RK.

Neurosurg Focus. 2006 Apr 15;20(4):E11. Review.

PMID:
16709016
5.

Convection-enhanced delivery in clinical trials.

Hall WA, Rustamzadeh E, Asher AL.

Neurosurg Focus. 2003 Feb 15;14(2):e2. Review.

PMID:
15727423
6.

Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.

Kioi M, Husain SR, Croteau D, Kunwar S, Puri RK.

Technol Cancer Res Treat. 2006 Jun;5(3):239-50. Review.

PMID:
16700620
7.

A comprehensive outlook on intracerebral therapy of malignant gliomas.

Buonerba C, Di Lorenzo G, Marinelli A, Federico P, Palmieri G, Imbimbo M, Conti P, Peluso G, De Placido S, Sampson JH.

Crit Rev Oncol Hematol. 2011 Oct;80(1):54-68. doi: 10.1016/j.critrevonc.2010.09.001. Epub 2010 Oct 2. Review.

PMID:
20888252
8.

Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.

Ferguson S, Lesniak MS.

Curr Drug Deliv. 2007 Apr;4(2):169-80. Review.

PMID:
17456036
9.

Technology evaluation: cintredekin besudotox, NeoPharm/Nippon.

Rainov NG, Söling A.

Curr Opin Mol Ther. 2005 Apr;7(2):170-81. Review.

PMID:
15844626
10.

Clinical studies with targeted toxins in malignant glioma.

Rainov NG, Söling A.

Rev Recent Clin Trials. 2006 May;1(2):119-31. Review.

PMID:
18473963
11.

Convection-enhanced delivery of targeted toxins for malignant glioma.

Hall WA, Sherr GT.

Expert Opin Drug Deliv. 2006 May;3(3):371-7. Review.

PMID:
16640497
12.

Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.

Juratli TA, Schackert G, Krex D.

Pharmacol Ther. 2013 Sep;139(3):341-58. doi: 10.1016/j.pharmthera.2013.05.003. Epub 2013 May 18. Review.

PMID:
23694764
13.

Convection-enhanced delivery: targeted toxin treatment of malignant glioma.

Hall WA, Sherr GT.

Neurosurg Focus. 2006 Apr 15;20(4):E10. Review.

PMID:
16709015
14.
15.

Convection-enhanced delivery for treatment of brain tumors.

Ferguson SD, Foster K, Yamini B.

Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S79-85. doi: 10.1586/14737140.7.12s.S79. Review.

PMID:
18076322
16.

Targeted drug delivery for treatment and imaging of glioblastoma multiforme.

Stukel JM, Caplan MR.

Expert Opin Drug Deliv. 2009 Jul;6(7):705-18. doi: 10.1517/17425240902988470. Review.

PMID:
19538036
17.

Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy.

Kawakami M, Kawakami K, Puri RK.

J Neurooncol. 2003 Oct;65(1):15-25. Review.

PMID:
14649882
18.

Crossing borders: surgically mediated drug delivery techniques.

Asthagiri AR, Baggenstos M, Lonser RR.

Clin Neurosurg. 2008;55:27-34. Review. No abstract available.

PMID:
19248666
19.

Convection-enhanced delivery in the treatment of malignant glioma.

Lopez KA, Waziri AE, Canoll PD, Bruce JN.

Neurol Res. 2006 Jul;28(5):542-8. Review.

PMID:
16808887
20.

Convection-enhanced delivery of immunotoxins and radioisotopes for treatment of malignant gliomas.

Vandergrift WA, Patel SJ, Nicholas JS, Varma AK.

Neurosurg Focus. 2006 Apr 15;20(4):E13. Review.

PMID:
16709018

Supplemental Content

Support Center